NCT03789630

Brief Summary

The aim of this observational study is to assess whether patient reported pain levels correlate with a Pain Index derived from deviations in multivariate physiology biomarkers captured in real-world setting. This study will be conducted using a clinical-grade wearable sensor to continuously monitor patient's physiology (pain related biomarkers) and allow subject participant to actively report their pain score, symptoms and quality of life using a mobile-based application.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 28, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

February 2, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2020

Completed
Last Updated

October 27, 2022

Status Verified

October 1, 2022

Enrollment Period

1.5 years

First QC Date

December 27, 2018

Last Update Submit

October 25, 2022

Conditions

Keywords

Knee ReplacementWearablePain Score Quantification

Outcome Measures

Primary Outcomes (1)

  • Pain Correlation (using binary pain classification)

    Agreement between patient-reported NRS pain (classified into None-Mild and Moderate-Severe) and Pain Index, measured using Kappa statistic.

    30 days

Secondary Outcomes (2)

  • Pain Correlation in Opioid Medication Subgroup

    30 days

  • Pain Correlation (3 pain categories)

    30 days

Study Arms (1)

Monitoring arm

Monitoring subjects undergoing total knee replacement surgery using the wearable biosensor to continuously monitor physiology biomarkers.

Device: Continuous physiology monitoring in ambulatory setting pre and post surgery

Interventions

This study will recruit 55 patients aged 21 to 80 years who will be undergoing total knee replacement surgery. All study participants undergoing total knee replacement surgery will be monitored using the wearable biosensor to continuously monitor physiology biomarkers. Participants will be followed for an estimated total of 39 days, beginning four days before surgery, the entire period during in-patient recovery (four to five days), and 30-days post-discharge at-home.

Monitoring arm

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

55 study participants, aged between 21 to 80 years, regardless of gender, who is undergoing total knee replacement surgery will be enrolled for the study upon receiving informed consent.

You may qualify if:

  • Men and women aged 21 to 80 years
  • Patients undergoing knee replacement surgery ( Total Knee Replacement (TKR), Unicompartmental Knee arthroplasty (UKA), Bilateral knee replacemenent, Patello-Femoral-Joint (PFJ) Knee replacement), Anterior Cruciate Ligament(ACL), Knee Arthroscopy and Foot \& Ankle related surgery such as bunions, hammer toes, metatarsal, ankle fusion, triple fusion, ankle replacement, achilles tendon \& tibialis posterior disorder
  • Ability to provide informed consent
  • Able to commit to using the app and inputting data as needed during the study duration
  • Has access to an iPhone (minimum requirement iPhone 5S)

You may not qualify if:

  • Previous myocardial infarction (MI)
  • Known coronary artery disease - prior coronary revascularization
  • Previous stroke. Stroke is defined as new focal neurological deficit perspective more than 24 hours.
  • More than ongoing use of 2 or more anti-hypertensive agents.
  • Expected life expectancy less than 1 year.
  • Asthma or chronic lung disease requiring long-term medications or oxygen
  • Mental illness that in the clinical judgment of the investigator will affect participation in the study e.g. dementia
  • Inability to comply with the study protocol
  • Any other acute or chronic medical or physical condition deemed by the investigator to affect study outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore General Hospital (SGH)

Singapore, 169865, Singapore

Location

MeSH Terms

Interventions

Postoperative Period

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2018

First Posted

December 28, 2018

Study Start

February 2, 2019

Primary Completion

August 17, 2020

Study Completion

August 17, 2020

Last Updated

October 27, 2022

Record last verified: 2022-10

Locations